Abstract:Background The role of adjunctive injection agents at the end of temporomandibular joint (TMJ) arthrocentesis remains controversial. Purpose This study aims to compare pain reduction in patients with disc displacement without reduction (DDwoR) treated with arthrocentesis alone (AO), arthrocentesis with injectable platelet-rich fibrin (iPRF), and arthrocentesis with hyaluronic acid (HA). Study Design, Setting, and Sample A single-center, retrospective cohort study was conducted at the affiliated hospital of Health Sciences University, Hamidiye Faculty of Dentistry. Inclusion criteria were female subjects aged 18-65, who underwent TMJ unilateral arthrocentesis, and diagnosed with DDwoR. Exclusion criteria were prior use of occlusal splints, accompanying diagnosis of myalgia and bilateral arthralgia which both of the joints exceeds or equal to 50 mm visual analogue scale for pain (pVAS) value. Predictor Variable The primary predictor variable was the adjunctive injection agent: iPRF, HA, or no injection (AO as control). Main Outcome Variables Primary and secondary outcomes were measured pre-operatively (T0), and at 1 month (T1) and 6 months (T2) post-operatively. The primary outcome was pain (pVAS) at T2. Secondary outcomes were pVAS at T1 and maximum interincisal opening (MIO) at T1 and T2. Covariates Demographics, pre-operative and peri-operative data were collected. Analyses Descriptive, bivariate, and multivariate analyses were conducted. The p value was set at ≤0.05. Results A total of 88 subjects completed the study. The mean age of the subjects in the AO (n=30), HA (n=29) and iPRF (n=29) groups was 36.8 (±10.2) , 34.8 (±8.9) and 37.6 (±11.6) respectively (p>.05). The mean pVAS scores at T0 for the AO, HA and iPRF groups were 63.2 (±8.7), 66.7 (±9.6) and 66.2 (±9.6) respectively (p>.05). The mean pVAS scores at T1 were 36.5 (±10.8), 29.0(±11.5) and 35.9 (±9.8) respectively (p<.05). The mean pVAS scores at T2 were 34.8 (±16.3), 24.7 (±12.7) and 25.3 (±13.4) respectively (p .05). Conclusion iPRF and HA injections are associated with greater pain relief compared to AO. No significant difference was observed between iPRF and HA, suggesting that the choice between them can be based on cost-effectiveness.

Does Piroxicam have an Added Benefit on Arthrocentesis in the Management of Internal Derangement in Female Patients?: A Randomized Clinical Trial

Role of Intra-articular Piroxicam in the Temporomandibular Joint After Arthrocentesis for Anterior Disc Displacement Without Reduction

Arthrocentesis of Temporomandibular Joints—A Clinical Comparative Study

Does The Use Of Injectable Platelet-Rich Fibrin Following Arthrocentesis For Disc Displacement Without Reduction Alleviate Pain?

The benefits of performing temporomandibular joint arthrocentesis with catheters and a vacuum pump: A randomized control trial

Assessing the Efficacy of Arthrocentesis in Managing Temporomandibular Joint Disorders and Internal Derangements: A Case Series

[Influence of Intra-Articular Corticosteroid on the Efficacy of Arthrocentesis in Treatment of Temporomandibular Joint Anterior Disc Displacement Without Reduction].

Efficacy of Duloxetine With Arthrocentesis in the Management of TMJ Internal Derangement

Computer-guided versus conventional arthrocentesis in treatment of anterior disc displacement of temporomandibular joint

Does intra-articular injection of platelet-rich plasma/platelet-rich fibrin improve outcomes after temporomandibular joint arthrocentesis? A systematic review and meta-analysis

The Effect of Arthrocentesis Treatment for Maximum Mouth Opening and Pain in Temporomandibular Joint Diseases and the Effect of Splint, Drug, and Physical Therapy on This Treatment

Piroxicam and paracetamol in the prevention of early recurrent pain and emergency department readmission after renal colic: Randomized placebo‐controlled trial

Does the use of soft or hard splints affect the short-term outcome of temporomandibular joint arthrocentesis?

Is There A Superiority Between Arthrocentesis And Stabilizing Occlusal Splint For The Treatment Of Anterior Disc Displacement With Reduction And Intermittent Block And Anterior Disc Displacement Without Reduction In Tmj? - Randomized Clinical Trial

Effectiveness of Ultrasound Guidance on Intraarticular and Periarticular Joint Injections: Systematic Review and Meta-analysis of Randomized Trials.

Arthrocentesis versus occlusal coverage splints in the management of disc displacement without reduction: a systematic review and meta-analysis

Does intra-articular injection of tenoxicam after arthrocentesis heal outcomes of temporomandibular joint osteoarthritis? A randomized clinical trial

Evaluation of the effect of intra-articular injection of macrolide antibiotics versus corticosteroids on internal derangement of temporomandibular joint.

Treatment of painful temporomandibular joint disc displacement without reduction: network meta-analysis of randomized clinical trials

Effect of sublingual fast-dissolving piroxicam premedication on postoperative pain experience in mandibular molars with non-vital pulp: a randomized double-blind controlled trial

COMPARISON OF CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS WITH AND WITHOUT INTRA-ARTICULAR PLATELET RICH PLASMA INJECTION IN THE ALTERATION OF DISEASE PROGRESSION OF EARLY RHEUMATOID ARTHRITIS: A RANDOMIZED CONTROLLED TRIAL